Dr. James Mule (2002, 2003, 2004)
Dr. James J. Mule is Associate Center Director for
Translational Research & Technology Development
and the U.S. Senator Connie Mack & Family Distinguished
Chair, Melanoma Research and Treatment, at the H. Lee
Moffitt Comprehensive Cancer Center & Hospital.
He was the Director of the Tumor Immunology and Immunotherapy
Clinical Research Program at the University of Michigan
Comprehensive Cancer Center. Dr. Mule was also the Maude
T. Lane Endowed Professor of Surgery, Department of
Surgery and held the appointment of Professor in the
Department of Internal Medicine. He is recognized for
his translational research studies in cancer immunotherapy.
His research group is involved in vaccine strategies
and other approaches to stimulate the immune system
to recognize and destroy tumors. The work in these areas
has helped to develop new treatments for advanced cancer
patients. Dr. Mule serves on the advisory boards of
nine NCI-designated Comprehensive Cancer Centers and
is a member of the National Cancer Institutefs Board
of Scientific Counselors; he is also a member of the
Center for Biologics Evaluation and Review, Food and
Drug Administrationfs External Board of Advisers. Dr.
Mule has published nearly 200 articles in the areas
of cancer vaccines and cancer immunotherapy.